对我国电子竞技运动发展现状的思考

我国电子竞技运动的发展目前还处于初级阶段,没有统一固定的专业组织,没有规范有序的竞赛市场,广大电子竞技爱好者的运动水平难以获得大的提高. 要想改变现状,跟上世界电子竞技运动的发展步伐,我们必须创新理念. 首先,获得政府的支持和观众的广泛参与,争取企业的赞助,制定政策,完善赛制,使电子竞技迈上发展的正常轨道;其次,走职业化、产业化道路,探索产业赢利模式,培育和开发市场;第三,博采众长,形成中国电子竞技运动的特色,打造自己的品牌,促进整个信息产业和体育事业的发展.     

Seismic 3D Prestack Time Migration on Parallel Computers

Ｓｅｉｓｍｉｃ３ＤＰｒｅｓｔａｃｋＴｉｍｅＭｉｇｒａｔｉｏｎｏｎＰａｒａｌｌｅｌＣｏｍｐｕｔｅｒｓ￥ＬｉｕＰｉｎｇ＆ＣｈｅｎＹｕｎｈｅ（ＷｕｈａｎＤｉｇｉｔａｌＥｎｇｉｎｅｅｒｉｎｇｉｎｓｔｉｔｕｔｅ，ＷｕｃｈａｎｇＰ．Ｏ．Ｂｏｘ７４２２３，Ｐ．Ｒ．...     

Windows环境下光伏水泵报价系统的实现

该文介绍了在Ｗｉｎｄｏｗｅ３．１环境下．利用ＭｉｃｒｏｓｏｆｔＣ（＋＋）及其基本类库（ＭＦＣ）开发光伏水泵报价系统的方法。该方法采用了面向对象技术，使软件具备可重用性。同时，ＭＦＣ类库的使用使复杂的Ｗｉｎ－ｄｏｗｓ应用程序的编程接口变得更容易。该方法对其它工程报价问题也具借鉴意义。     

A new indolic antiauxin, α-(5,7-dichloroindole-3-)isobutyric acid: its chemical synthesis and biological activity

Summary A new potent antiauxin, -(5,7-dichloroindole-3-)isobutyric acid has been synthesized and shown to inhibit auxin-mediated elongation ofAvena coleoptiles and to stimulate root growth of rice seedlings. Its activity is stronger than -(p-chlorophenoxy)isobutyric acid and is comparable to that of 2,3,5-triiodobenzoic acid, which are typical antiauxins.     

Pharmacodynamic profile of CQP 201-403, a novel 8α-amino-ergoline

Summary The profile of action in animals of CQP 201-403, a novel 8-amino-ergoline, is in most aspects that of a very potent dopaminomimetic, both as a prolactin secretion inhibitor, and at the levels of the CNS and the cardiovascular system. Qualitatively CQP 201-403 differs slightly from bromocriptine and apomorphine in its effects on the CNS (no influence on serotonin metabolism in the rat cortex; induction of masculine mounting behavior in rats) and the cardiovascular system of the dog (reflex tachycardia in response to a blood-pressure fall). In man the new compound proved to be highly active in lowering prolactin serum levels and to be more potent than bromocriptine (Parlodel^®).In memory of Dr Annemarie Closse, who died 14 June 1987.     

一种防空C~3I系统的效能分析方法

本文讨论了一种评定C~3I系统效能的方法。这种方法是根据系统完成使命的能力和系统的内部结构两方面的分析来完成的。通过对IFFN系统的评定,对本方法进行了举例说明。     

Purification of platelet-derived endothelial cell growth inhibitor and its characterization as transforming growth factor-β type 1

In 1986, Brown and Clemmons (Proc. natl Acad. Sci. USA83 (1986) 3321) showed that platelets contain a substance, platelet-derived growth inhibitor (PDGI), that inhibits in vitro endothelial cell replication. Although platelets are rich in transforming grwoth factor (TGF-), PDGI was considered not to be related to TGF-, on the basis of its reported properties (extraction from platelets at neutral pH, binding to heparin-Sepharose). However, we purified PDGI to near homogeneity and showed that on the basis of HPLC retention behavior, in vitro growth inhibitory activities with several cell types, receptor binding, and immunoneutralization of growth inhibitory activity with specific anti-TGF- type 1 antibodies, PDGI is most probably identical with TGF- type 1.     

Flow-induced release of adenosine 5′-triphosphate from endothelial cells of the rat mesenteric arterial bed

Adenosine 5-triphosphate (ATP) was released into the perfusate of rat isolated mesenteric arterial beds during each of two consecutive increases in flow. There was no significant difference between the amounts of ATP released on each occasion. Substance P was also released into the perfusate by increased flow, although its release was more variable. Removal of the endothelium of the mesenteric vessels with sodium deoxycholate led to a significant reduction (74%) in the amount of ATP released compared with the release before the endothelium had been removed. This suggests that the ATP released into the mesenteric arterial perfusate during increased flow arises from endothelial cells.     

用焓法有限元解相变问题的离散化方法

为了消除应用焓法进行含有相变的有限元传热计算结果呈台阶形的现象,本文作者提出“焓计算单元”和“固相分数”的概念,并将几种一维有限元实施方案的计算结果与精确解对比,说明采用所提出的概念,可以使有限元计算得出更为合理的结果。     

Determination of erythrocyte pyrimidine 5′-nucleotidase activity by31P nuclear magnetic resonance: Comparison of normal controls and multiple sclerosis patients

Summary A technique to assay erythrocyte pyrimidine 5-nucleotidase activity in situ using³¹P nuclear magnetic resonance spectroscopy is presented. The assay is chemically specific, simple and applicable to untreated lysates. A comparison of enzyme levels in normal controls and in multiple sclerosis patients employing the assay yielded no significant differences between both groups. Difficulties encountered in the quantitative analysis of the assay using¹H-NMR spectroscopy are briefly discussed.